The high expression of both thioredoxin 1 (Trx1) and thioredoxin reductase 1 (TrxR1) is observed in several human cancers, including breast cancer, and the over-expression of Trx1 in MDA-MB-231 breast cancer cell lines promoted an aggressive phenotype [5]. Here, TXN is linked to breast carcinoma.